Cel Sci (CVM) Gains (Losses) on Sale of Assets & Investments (2010 - 2015)
Cel Sci (CVM) recorded Non Operating Investment Income of -$115.00 in fiscal Q1 2016 (quarter ended Dec 31, 2015), compared with -$313.00 a year earlier.
Powered by 
Analysis
Cel Sci (CVM) Gains (Losses) on Sale of Assets & Investments (2010 - 2015) Analysis & Trends
For FY2015 (ended Sep 30, 2015), Cel Sci reported Non Operating Investment Income of $313.00, down 73.5% from FY2014.
- Annual Non Operating Investment Income has declined for three straight fiscal years, with a five-year compound annual growth rate of -53.2% (FY2010 to FY2015).
- Across earlier fiscal years, Non Operating Investment Income came in at $1,182 in FY2014 (-94.8%), $22,628 in FY2013 (-49.6%), $44,921 in FY2012 (+398.2%) and $9,016 in FY2011 (-35.0%).
- Quarterly Non Operating Investment Income has ranged from -$2,591 in fiscal Q3 2011 to $16,018 in fiscal Q3 2012 over the past five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Cel Sci | 58.11 Mn | 32.46 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | -115.00 |
| Sep 30, 2015 | 626.00 |
| Dec 31, 2014 | -313.00 |
| Sep 30, 2014 | 1,182.00 |
| Jun 30, 2014 | -240.00 |
| Mar 31, 2014 | 480.00 |
| Dec 31, 2013 | -240.00 |
| Sep 30, 2013 | 11,977.00 |
| Mar 31, 2013 | 428.00 |
| Dec 31, 2012 | 10,223.00 |
| Sep 30, 2012 | 7,569.00 |
| Jun 30, 2012 | 16,018.00 |
| Mar 31, 2012 | 13,379.00 |
| Dec 31, 2011 | 7,955.00 |
| Sep 30, 2011 | 11,844.00 |
| Jun 30, 2011 | -2,591.00 |
| Dec 31, 2010 | -237.00 |
API Access
Cel Sci Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();